CDC Reports Seven Cases of Illness After Possible Counterfeit Botox Injections
Seven patients with illness identified after presumed cosmetic botulinum neurotoxin (BoNT) product injection are described in a case report published in the July 11 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Christine M. Thomas, D.O., from the CDC in Atlanta, and colleagues characterized illnesses identified after presumed cosmetic BoNT injections and examined implicated BoNT products.
Source: Advances and More licensed by HealthDay
